Deprescribing proton pump inhibitors Evidence-based clinical practice guideline

被引:3
|
作者
Farrell, Barbara [1 ,2 ,3 ]
Pottie, Kevin [4 ,5 ,6 ]
Thompson, Wade [5 ]
Boghossian, Taline [7 ]
Pizzola, Lisa [6 ]
Rashid, Farah Joy [7 ]
Rojas-Fernandez, Carlos [8 ,9 ]
Walsh, Kate [10 ]
Welch, Vivian [5 ,11 ]
Moayyedi, Paul [12 ]
机构
[1] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada
[2] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada
[3] Univ Ottawa, Bruyere Res Inst, Ottawa, ON, Canada
[4] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada
[5] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[6] Bruyere Res Inst, Ottawa, ON, Canada
[7] Ottawa Hosp, Dept Pharm, Ottawa, ON, Canada
[8] Univ Waterloo, Geriatr Pharmacotherapy, Schlegel UW Res Inst Ageing, Waterloo, ON, Canada
[9] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada
[10] Toronto Cent Community Care Access Ctr, Toronto, ON, Canada
[11] Bruyere Res Inst, Methods Ctr, Ottawa, ON, Canada
[12] McMaster Univ, Div Gastroenterol, Hamilton, ON, Canada
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; PANTOPRAZOLE; 20; MG; MAINTENANCE TREATMENT; LONG-TERM; ON-DEMAND; CONTROLLED TRIAL; PRIMARY-CARE; THERAPY; ESOPHAGITIS; MANAGEMENT;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper or stop proton pump inhibitors (PPIs); to focus on the highest level of evidence available and seek input from primary care professionals in the guideline development, review, and endorsement processes. Methods Five health professionals (1 family physician, 3 pharmacists, and 1 gastroenterologist) and 5 nonvoting members comprised the overall team; members disclosed conflicts of interest. The guideline process included the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach, with a detailed evidence review in in-person, telephone, and online meetings. Uniquely, the guideline development process included a systematic review of PPI deprescribing trials and examination of reviews of the harm of continued PPI use. Narrative syntheses of patient preferences and resource-implication literature informed recommendations. The team refined guideline content and recommendation wording through consensus and synthesized clinical considerations to address common front-line clinician questions. The draft guideline was distributed to clinicians and then to health care professional associations for review and revisions made at each stage. A decision-support algorithm was developed in conjunction with the guideline. Recommendations This guideline recommends deprescribing PPIs (reducing dose, stopping, or using "on-demand" dosing) in adults who have completed a minimum of 4 weeks of PPI treatment for heartburn or mild to moderate gastroesophageal reflux disease or esophagitis, and whose symptoms are resolved. The recommendations do not apply to those who have or have had Barrett esophagus, severe esophagitis grade C or D, or documented history of bleeding gastrointestinal ulcers. Conclusion This guideline provides practical recommendations for making decisions about when and how to reduce the dose of or stop PPIs. Recommendations are meant to assist with, not dictate, decision making in conjunction with patients.
引用
收藏
页码:354 / 364
页数:11
相关论文
共 50 条
  • [1] Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review
    Rossi, Andrea
    Perrella, Lara
    Scotti, Stefano
    Olmastroni, Elena
    Galimberti, Federica
    Ardoino, Ilaria
    Orlando, Valentina
    Menditto, Enrica
    Franchi, Carlotta
    Casula, Manuela
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [2] Problems Associated with Deprescribing of Proton Pump Inhibitors
    Helgadottir, Holmfridur
    Bjornsson, Einar S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [3] Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia Evidence-based clinical practice guideline
    Bjerre, Lise M.
    Farrell, Barbara
    Hogel, Matthew
    Graham, Lyla
    Lemay, Genevieve
    McCarthy, Lisa
    Raman-Wilms, Lalitha
    Rojas-Fernandez, Carlos
    Sinha, Samir
    Thompson, Wade
    Welch, Vivian
    Wiens, Andrew
    CANADIAN FAMILY PHYSICIAN, 2018, 64 (01) : 17 - 27
  • [4] Deprescribing proton pump inhibitors: why, when and how
    Bytzer, Peter
    MEDICAL JOURNAL OF AUSTRALIA, 2018, 209 (10) : 436 - +
  • [5] Deprescribing proton pump inhibitors
    Turner, Justin P.
    Thompson, Wade
    Reeve, Emily
    Bell, J. Simon
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (11) : 845 - 848
  • [6] Feasibility of a Patient-Centered Deprescribing Process to Reduce Inappropriate Use of Proton Pump Inhibitors
    Reeve, Emily
    Andrews, Jane M.
    Wiese, Michael D.
    Hendrix, Ivanka
    Roberts, Michael S.
    Shakib, Sepehr
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (01) : 29 - 38
  • [7] Deprescribing strategies for proton pump inhibitors
    Young, Julia
    Fuller, Jordan A.
    Guidry, Corey M.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2024, 37 (11): : 51 - 51
  • [8] Proton pump inhibitors and their drug interactions: an evidence-based approach
    Gerson, LB
    Triadafilopoulos, G
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (05) : 611 - 616
  • [9] Intravenous Proton Pump Inhibitors An Evidence-Based Review of Their Use in Gastrointestinal Disorders
    Bardou, Marc
    Martin, Janet
    Barkun, Alan
    DRUGS, 2009, 69 (04) : 435 - 448
  • [10] Acupuncture for cancer pain: an evidence-based clinical practice guideline
    Ge, Long
    Wang, Qi
    He, Yihan
    Wu, Darong
    Zhou, Qi
    Xu, Nenggui
    Yang, Kehu
    Chen, Yaolong
    Zhang, Anthony Lin
    Hua, Haiqing
    Huang, Jinchang
    Hui, Ka-Kit
    Liang, Fanrong
    Wang, Linpeng
    Xu, Bin
    Yang, Yufei
    Zhang, Weimin
    Zhao, Baixiao
    Zhu, Bing
    Guo, Xinfeng
    Xue, Charlie Changli
    Zhang, Haibo
    Xue, Charlie Changli
    Xue, Charlie Changli
    Zhang, Haibo
    Guo, Xinfeng
    Wu, Darong
    Yang, Kehu
    Chen, Yaolong
    Ge, Long
    He, Runsen
    Hua, Haiqing
    Huang, Jinchang
    Hui, Ka-Kit
    Liang, Fanrong
    Pan, Zuodi
    Wang, Linpeng
    Xu, Bin
    Xu, Nenggui
    Yang, Yufei
    Zhang, Anthony Lin
    Zhang, Weimin
    Zhao, Baixiao
    Zhu, Bing
    Wang, Qi
    He, Yihan
    Zhou, Qi
    Yang, Lihong
    Liu, Shaonan
    Li, Jieyun
    CHINESE MEDICINE, 2022, 17 (01)